Gastrointestinal complications in pediatric lung transplant recipients: Incidence, risk factors, and effects on patient outcomes

被引:0
作者
Klouda, Timothy [1 ]
Ryan, E. Morgan [1 ]
Leonard, Jessica Brie [2 ]
Freiberger, Dawn [1 ]
Midyat, Levent [1 ]
Dahlberg, Suzanne [1 ]
Rosen, Rachel [2 ]
Visner, Gary [1 ]
机构
[1] Boston Childrens Hosp, Div Pulm Med, 300 Longwood Ave,BCH3121, Boston, MA 02115 USA
[2] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA USA
关键词
GI comorbidities; graft failure; pediatric lung transplant; risk factors; GASTROESOPHAGEAL-REFLUX; INTERNATIONAL SOCIETY; HEART; GASTROPARESIS; REPORT-2018; PREVALENCE; ASPIRATION; REGISTRY;
D O I
10.1111/petr.14665
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
BackgroundGastrointestinal (GI) complications in lung transplant recipients can occur any time during the post-operative period, leading to prolonged morbidity and mortality. Despite the negative association between GI complications and patient outcomes, little is known about their incidence and risk factors for their development in pediatric lung transplant recipients.MethodsWe performed a retrospective chart review at one pediatric tertiary center to describe the frequency of GI complications in lung transplant recipients. We identified potential risk factors for the diagnosis of gastroparesis, gastroesophageal reflux disease (GERD) and aspiration in the post-transplant period. Lastly, we investigated the association of these complications with mortality and graft survival.Results84.3% of lung transplant recipients experienced at least one GI complication in the post-transplant period. Gastroparesis (52.9%), GERD (41.2%), and oropharyngeal dysphagia/laryngeal penetration (33.3%) were the most common complications diagnosed. Post-operative opioid exposure was a risk factor for gastroparesis, with the odds increasing 3.0% each day a patient was prescribed opioids (p = .021). The risk of death or retransplant in individuals who experienced gastroparesis was 2.7 times higher than those not diagnosed with gastroparesis (p = .027).ConclusionExposure to opioids in the post-operative period is a risk factor for gastroparesis and a prolonged hospitalization placed patients at risk for aspiration. Gastroparesis was associated with increased patient mortality and graft failure, while aspiration and GERD had no effect on long term outcomes. Future prospective studies investigating the relationship between opioid use and the development of a gastroparesis are necessary to improve patient outcomes.
引用
收藏
页数:9
相关论文
共 35 条
  • [1] GASTROPARESIS AFTER LUNG TRANSPLANTATION - POTENTIAL ROLE IN POSTOPERATIVE RESPIRATORY COMPLICATIONS
    BERKOWITZ, N
    SCHULMAN, LL
    MCGREGOR, C
    MARKOWITZ, D
    [J]. CHEST, 1995, 108 (06) : 1602 - 1607
  • [2] Swallowing and laryngeal complications in lung and heart transplantation: Etiologies and diagnosis
    Black, Rebecca J.
    Novakovic, Daniel
    Plit, Marshall
    Miles, Anna
    MacDonald, Peter
    Madill, Catherine
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (12) : 1483 - 1494
  • [3] Prevalence and management of gastrointestinal complications in lung transplant patients:: MITOS study group
    Bravo, C.
    Gispert, P.
    Borro, J. M.
    de la Torre, M.
    Martinez, J. M. Cifrian
    Rozas, S. Fernandez
    Goni, F. Zurbano
    [J]. TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2409 - 2412
  • [4] Early Fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease
    Cantu, E
    Appel, JZ
    Hartwig, MG
    Woreta, H
    Green, C
    Messier, R
    Palmer, SM
    Davis, RD
    [J]. ANNALS OF THORACIC SURGERY, 2004, 78 (04) : 1142 - 1151
  • [5] Gastroesophageal reflux and altered motility in lung transplant rejection
    Castor, J. M.
    Wood, R. K.
    Muir, A. J.
    Palmer, S. M.
    Shimpi, R. A.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2010, 22 (08) : 841 - 850
  • [6] The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth adult lung and heart-lung transplant report-2018; Focus theme: Multiorgan Transplantation
    Chambers, Daniel C.
    Cherikh, Wida S.
    Goldfarb, Samuel B.
    Hayes, Don, Jr.
    Kucheryavaya, Anna Y.
    Toll, Alice E.
    Khush, Kiran K.
    Levvey, Bronwyn J.
    Meiser, Bruno
    Rossano, Joseph W.
    Stehlik, Josef
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (10) : 1169 - 1183
  • [7] Report from the 2018 consensus conference on immunomodulating agents in thoracic transplantation: Access, formulations, generics, therapeutic drug monitoring, and special populations
    Cochrane, Adam B.
    Lyster, Haifa
    Lindenfeld, JoAnn
    Doligalski, Christina
    Baran, David
    Yost, Colleen
    Shullo, Michael
    Schweiger, Martin
    Weill, David
    Stuckey, Linda
    Ivulich, Steven
    Scheel, Janet
    Peters, Lisa
    Colvin, Monica
    Dawson, Kyle
    Girgis, Reda
    Weeks, Phillip
    Tse, Tracy
    Russell, Stuart
    Flattery, Maureen
    Jennings, Doug
    Kittleson, Michelle
    Miller, Tara
    Khuu, Tam
    Claridge, Tamara
    Uber, Patricia
    Ford, Katrina
    Ensor, Christopher R.
    Simpson, Kathleen
    Dipchand, Anne
    Page, Robert L., II
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (10) : 1050 - 1069
  • [8] Incidence, risk factors, and sequelae of dysphagia mediated aspiration following lung transplantation
    Dallal-York, Justine
    Segalewitz, Tara
    Croft, Kayla
    Colsky, Jennifer
    DiBiase, Lauren
    Anderson, Amber
    Vasilopoulos, Terrie
    Pelaez, Andres
    Shahmohammadi, Abbas
    Pipkin, Mauricio
    Machuca, Tiago N.
    Plowman, Emily K.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (08) : 1095 - 1103
  • [9] Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation
    Davis, RD
    Lau, CL
    Eubanks, S
    Messier, RH
    Hadjiliadis, D
    Steele, MP
    Palmer, SM
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (03) : 533 - 542
  • [10] Galligan JJ, 2017, HANDB EXP PHARMACOL, V239, P363, DOI 10.1007/164_2016_116